Detalhe da pesquisa
1.
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype.
Breast Cancer
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38777987
2.
Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.
Drug Resist Updat
; 15(1-2): 50-61, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22464282
3.
A Histone Deacetylase Inhibitor Induces Acetyl-CoA Depletion Leading to Lethal Metabolic Stress in RAS-Pathway Activated Cells.
Cancers (Basel)
; 14(11)2022 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681624
4.
Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy.
Cancer Res Commun
; 2(8): 857-869, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36923306
5.
Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties.
Cell Death Dis
; 13(9): 787, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36104324
6.
Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cells.
Mol Cancer
; 10: 80, 2011 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21733184
7.
Histone deacetylase inhibitors: emerging mechanisms of resistance.
Mol Pharm
; 8(6): 2021-31, 2011 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21899343
8.
[Interest of the bc-GenExMiner web tool in oncology]. / Intérêt de l'outil web bc-GenExMiner en oncologie.
Bull Cancer
; 108(11): 1057-1064, 2021 Nov.
Artigo
em Francês
| MEDLINE | ID: mdl-34561023
9.
R-Loop-Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin.
Mol Cancer Res
; 19(8): 1361-1374, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050002
10.
BCL-XL directly modulates RAS signalling to favour cancer cell stemness.
Nat Commun
; 8(1): 1123, 2017 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29066722
11.
Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras.
Oncotarget
; 7(43): 69804-69815, 2016 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27634878
12.
Antitumor effect of pharmacologic ascorbate in the B16 murine melanoma model.
Free Radic Biol Med
; 87: 193-203, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26119785
13.
Histone deacetylase inhibitors induce CXCR4 mRNA but antagonize CXCR4 migration.
Cancer Biol Ther
; 14(2): 175-83, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23192271
14.
Histone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporter.
Cancer Res
; 72(14): 3642-51, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22472121
15.
Gout, genetics and ABC transporters.
F1000 Biol Rep
; 3: 23, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22065982
16.
Pancreatic cancer: Targeting KRAS and the vitamin D receptor via microtubules.
Nat Rev Clin Oncol
; 12(8): 442-4, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26169922